APTARGROUP, INC. ATR
Aptar is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing and protection technologies. Aptar serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care and home care. Using proprietary design, engineering, materials science, and manufacturing capabilities, Aptar supports customers across these end markets by enabling safe, functional, and differentiated product and service delivery. Aptar is headquartered in Crystal Lake, Illinois and has approximately 14,000 employees in approximately 20 different countries. For more information, visit www.aptar.com.
Our business was started in the late 1940's, manufacturing and selling aerosol valves in the United States, and has grown through acquisitions and organic growth. In this report, we may refer to AptarGroup, Inc. and its subsidiaries as "AptarGroup," "Aptar" or the "Company."
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by segment
- Pharma
- Beauty
- Closures
| Segment | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Pharma | $1.74B | $1.64B | $1.52B |
| Beauty | $1.31B | $1.23B | $1.27B |
| Closures | $730.3M | $714.0M | $698.8M |
As the company reported it, from the “REVENUE - Schedule of Revenue by Segment by Geographic Area (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.78B | $3.58B | $3.49B | $3.32B | $3.23B | $2.93B | $2.86B | $2.76B | $2.47B | $2.33B |
| Gross profit | — | — | — | — | — | $906.0M | $874.4M | $795.5M | $723.5M | $687.4M |
| R&D | $105.1M | $96.1M | $92.8M | $93.5M | $99.8M | $92.5M | $82.8M | $75.3M | $68.2M | $66.2M |
| Total operating expenses | $3.28B | $3.09B | $3.08B | $2.94B | $2.88B | $2.59B | $2.49B | $2.48B | $2.15B | $2.02B |
| Operating income | $501.0M | $496.5M | $404.0M | $379.3M | $347.3M | $339.5M | $371.7M | $286.3M | $323.5M | $313.7M |
| Interest expense | $52.7M | $43.9M | $40.4M | $40.8M | $30.3M | $33.2M | $35.5M | $32.6M | $40.6M | $35.2M |
| Pre-tax income | $491.4M | $469.8M | $374.8M | $334.7M | $321.7M | $301.2M | $342.1M | $266.0M | $294.8M | $280.5M |
| Income tax | $98.9M | $95.6M | $90.6M | $95.1M | $78.0M | $87.1M | $99.8M | $71.3M | $74.8M | $74.9M |
| Net income | $392.8M | $374.5M | $284.5M | $239.3M | $244.1M | $214.0M | $242.2M | $194.8M | $220.0M | $205.6M |
| EPS, basic | 5.97 | 5.65 | 4.34 | 3.66 | 3.72 | 3.32 | 3.81 | 3.12 | 3.52 | 3.27 |
| EPS, diluted | 5.89 | 5.53 | 4.25 | 3.59 | 3.61 | 3.21 | 3.66 | 3.00 | 3.41 | 3.17 |
| Shares, diluted (wtd. avg.) | 66.7M | 67.7M | 66.9M | 66.7M | 67.7M | 66.7M | 66.2M | 65.0M | 64.6M | 64.8M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $402.4M | $223.8M | $223.6M | $142.7M | $122.9M | $305.0M | $247.0M | $266.8M | $712.6M | $466.3M |
| Short-term investments | $7.1M | $2.3M | $0 | $0 | $740.0K | $243.0K | $0 | — | — | — |
| Receivables | — | $658.1M | $677.8M | $677.0M | $671.0M | $567.0M | — | — | — | — |
| Inventory | $537.8M | $461.8M | $513.1M | $486.8M | $441.5M | $379.4M | $375.8M | $381.1M | $337.2M | $296.9M |
| Total current assets | $1.89B | $1.48B | $1.55B | $1.43B | $1.36B | $1.37B | $1.29B | $1.33B | $1.67B | $1.27B |
| Property, plant and equipment | $1.68B | $1.45B | $1.48B | $1.34B | $1.28B | $1.20B | $1.09B | $991.6M | $867.9M | $784.3M |
| Goodwill | $1.08B | $936.3M | $963.4M | $945.6M | $974.2M | $898.5M | $763.5M | $712.1M | $443.9M | $407.5M |
| Other intangibles | $255.3M | $254.8M | $283.2M | $315.7M | $362.3M | $344.3M | $291.1M | $254.9M | $95.5M | $94.5M |
| Total assets | $5.25B | $4.43B | $4.45B | $4.20B | $4.14B | $3.99B | $3.56B | $3.38B | $3.14B | $2.61B |
| Short-term debt | $183.9M | $176.0M | $81.8M | $3.8M | $147.3M | $52.2M | $44.3M | $101.3M | $4.3M | $169.2M |
| Total current liabilities | $1.17B | $1.07B | $1.25B | $917.2M | $982.5M | $780.3M | $683.3M | $689.2M | $527.7M | $543.0M |
| Retained earnings | $2.64B | $2.37B | $2.11B | $1.93B | $1.79B | $1.64B | $1.52B | $1.37B | $1.30B | $1.20B |
| Total equity | $2.67B | $2.47B | $2.32B | $2.07B | $1.98B | $1.85B | $1.57B | $1.42B | $1.31B | $1.17B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $570.0M | $643.4M | $575.2M | $478.6M | $363.4M | $570.2M | $514.5M | $313.6M | $324.7M | $325.3M |
| Depreciation and amortisation | $287.4M | $263.8M | $248.6M | $233.7M | $234.9M | $220.3M | $194.6M | $171.7M | $153.1M | $154.8M |
| Stock-based compensation | $43.9M | $47.6M | $41.3M | $40.9M | $38.9M | $34.1M | $23.9M | $19.6M | $18.9M | $19.8M |
| Capital expenditure | $270.4M | $276.5M | $312.3M | $310.4M | $307.9M | $246.0M | $242.3M | $211.3M | $156.6M | $129.0M |
| Investing cash flow | -$331.4M | -$396.7M | -$324.5M | -$295.6M | -$457.2M | -$452.0M | -$336.3M | -$735.5M | -$224.8M | -$300.5M |
| Financing cash flow | -$77.5M | -$225.3M | -$171.6M | -$162.1M | -$81.5M | -$73.7M | -$197.1M | -$14.9M | $114.8M | -$29.7M |
| Dividends paid | $120.8M | $114.1M | $103.7M | $99.5M | $98.5M | $92.7M | $90.2M | $82.3M | $79.9M | $76.7M |
| Buybacks | $365.0M | $68.6M | $47.6M | $92.1M | $78.1M | $0 | $86.5M | $3.9M | $120.5M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000896622-26-000007.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.33B | $2.47B | $2.76B | $2.86B | $2.93B | $3.23B | $3.32B | $3.49B | $3.58B | $3.78B |
| Gross profit | $687.4M | $723.5M | $795.5M | $874.4M | $906.0M | — | — | — | — | — |
| Net income | $205.6M | $220.0M | $194.8M | $242.2M | $214.0M | $244.1M | $239.3M | $284.5M | $374.5M | $392.8M |
Recent filings and events
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Officer or director change Item 5.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Results announced Item 2.02
- Officer or director change Item 5.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Results announced Item 2.02
- Results announced Item 2.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 3089
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| ENTG | ENTEGRIS INC | $20.55B | 86.8x | -1.4% |
| AWI | ARMSTRONG WORLD INDUSTRIES INC | $7.11B | 23.8x | 12.1% |
| NWL | NEWELL BRANDS INC. | $2.28B | — | -5.0% |
| MYE | MYERS INDUSTRIES INC | $1.21B | 34.5x | -1.3% |
| KRT | Karat Packaging Inc. | $1.06B | 34.0x | 10.7% |
| SWIM | Latham Group, Inc. | $781.8M | 73.8x | 7.4% |
| CMT | CORE MOLDING TECHNOLOGIES INC | $204.7M | 17.9x | -9.5% |
| DSWL | DESWELL INDUSTRIES INC | — | — | -9.3% |